Welcome, you are shopping with

Tirzepatide Longevity Microdose

$299 /month

3 Month Minimum Requirement
Price includes doctor consultation and shipping fees.

(4.5 stars) • 131 reviews

Microdosing tirzepatide has shown promise in optimizing metabolism, improving blood sugar regulation, supporting cardiovascular health, reducing inflammation, and promoting cellular health. As a dual GIP/GLP-1 receptor agonist, tirzepatide may help enhance insulin sensitivity, reduce body fat, stabilize blood sugar levels, and lower inflammation. By supporting metabolic function and appetite control, tirzepatide may contribute to long-term longevity, health and well-being. Consult with a licensed healthcare provider to see if tirzepatide is right for you. Safe and effective use requires a prescription.

State Availability: 

Currently Not Available In: AL, AR, CA, HI, KS, MI, MN, MS (We are working on expanding our coverage in the near future).

Appetite Regulation and Promote Sustained Weight Loss:

Tirzepatide acts on both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors, helping to promote satiety, reduce appetite, and regulate blood sugar levels. Even at lower doses, microdosing tirzepatide may help manage weight by curbing hunger, reducing cravings, and encouraging smaller meal sizes. While primarily an off label longevity product, microdosing tirzepatide may assist with gradual, sustained weight loss for those looking to maintain a healthy weight.

Improved Blood Sugar Control:

Tirzepatide is designed to regulate blood glucose by stimulating insulin production and lowering glucagon secretion in response to meals. Microdosing may help stabilize blood sugar levels, particularly beneficial for individuals with prediabetes or mild insulin resistance, helping to prevent glucose spikes and crashes.

Reduced Inflammation:

As a dual receptor agonist, tirzepatide has shown anti-inflammatory effects, which are important in reducing chronic, low-grade inflammation. This may lower the risk of cardiovascular diseases and metabolic disorders, supporting overall longevity.

Improved Cardiovascular Health:

Tirzepatide may help reduce the risk of cardiovascular events by improving cholesterol levels, lowering blood pressure, and promoting weight loss. Microdosing could provide these cardiovascular benefits without requiring full therapeutic doses.

Enhancement of Metabolic Health:

Tirzepatide is known to improve insulin sensitivity, which supports long-term weight maintenance, energy balance, and reduces the risk of metabolic disorders like type 2 diabetes.

Neuroprotective Effects:

Early research indicates that tirzepatide, through its effects on GIP and GLP-1 receptors, may offer neuroprotective benefits, potentially lowering the risk of neurodegenerative diseases like Alzheimer’s. Microdosing may offer cognitive protection over time.

  • 90 day supply, billed up front
  • Option to renew or cancel every 3 months
  • Doctor review within 48 hours
  • Processing can take 7 – 10 business days (subject to pharmacy partners)
  • Once ready, shipping is via 2-day

The potential benefits of microdosing tirzepatide are promising, but it is important to consult a healthcare professional before starting any treatment. Tirzepatide may cause side effects, and its long-term effects are still being studied. Compounded medications are not FDA-approved. This information is for educational purposes only and does not replace medical advice. Microdosing tirzepatide is not FDA-approved for longevity, and individual results may vary. Always consult your primary care provider before beginning any new treatment.

Testimonials

Read what our customers have to say about our products.

Scientific Sources

1. Appetite Regulation and Sustained Weight Loss:

  • Study: In a clinical trial, tirzepatide significantly reduced body weight and improved glycemic control in participants with type 2 diabetes, showcasing its effects on satiety and appetite regulation.
  • Source: Jastreboff, A.M., et al. (2022). “Tirzepatide Once Weekly for the Treatment of Obesity.” New England Journal of Medicine, 387, 205-216. DOI: 10.1056/NEJMoa2206038

2. Improved Blood Sugar Control:

  • Study: Tirzepatide outperformed other GLP-1 receptor agonists and significantly improved HbA1c levels in patients with type 2 diabetes, indicating its effectiveness in stabilizing blood sugar.
  • Source: Frías, J.P., et al. (2021). “Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes.” New England Journal of Medicine, 385, 503-515. DOI: 10.1056/NEJMoa2107519

3. Reduced Inflammation:

  • Study: GLP-1 receptor agonists, including tirzepatide, have shown anti-inflammatory properties, helping to reduce chronic low-grade inflammation, which is linked to cardiovascular and metabolic diseases.
  • Source: Drucker, D.J. (2018). “Mechanisms of Action and Therapeutic Application of GLP-1 Receptor Agonists.” Lancet Diabetes Endocrinology, 6(12), 951-962. DOI: 10.1016/S2213-8587(18)30043-2

4. Improved Cardiovascular Health:

  • Study: Tirzepatide demonstrated improvements in cardiovascular risk factors such as lowering blood pressure, reducing triglycerides, and improving cholesterol levels in patients with type 2 diabetes.
  • Source: Rosenstock, J., et al. (2021). “Tirzepatide Reduces Cardiovascular Risk Factors in Patients with Type 2 Diabetes.” Diabetes Care, 44(9), 2171-2177. DOI: 10.2337/dc21-0271

5. Enhancement of Metabolic Health:

  • Study: Tirzepatide has been shown to improve insulin sensitivity and overall metabolic health, reducing the risks of developing type 2 diabetes and supporting weight management.
  • Source: Ludvik, B., et al. (2021). “Effects of Tirzepatide, a Dual GIP/GLP-1 Receptor Agonist, on Insulin Sensitivity in Type 2 Diabetes.” Diabetes, Obesity and Metabolism, 23(11), 2482-2487. DOI: 10.1111/dom.14555

6. Neuroprotective Effects:

  • Study: Research indicates that GLP-1 receptor agonists, including tirzepatide, may offer neuroprotective benefits and reduce the risks of neurodegenerative diseases like Alzheimer’s by reducing inflammation and oxidative stress.
  • Source: Hölscher, C. (2020). “Neuronal and Glial Protective Effects of Glucagon-like Peptide 1 (GLP-1) in Alzheimer’s Disease.” Current Alzheimer Research, 17(1), 5-14. DOI: 10.2174/1567205017666200102105707